The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Regional · North America · continued

Canadian access and provincial variation posts 61–81

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

MK
m.kjaerTL26 Feb 2025 · edited#61

Worth stating the null on canadian access and provincial variation before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.

3 likes 18mo
GT
g.tanakaTL3Regular6 Feb 2025#62
m.kjaer, post #61: Worth stating the null on canadian access and provincial variation before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one. Go to post

My position on canadian access and provincial variation is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.

11 likes in reply to #61 18mo
FR
f.rasmussenTL27 Feb 2025#63
a.ilunga, post #20: Regional variation in North America: access differs substantially by US state and Canadian province. Postcode is a major determinant of access. Go to post

The public assessment documents published at approval are free, detailed and largely unread here.

I would want a second opinion before relying on that.

33 likes in reply to #20 18mo
PN
priorauth_notesTL2Regular7 Feb 2025#64

Post #60 and I disagree about the size of the effect, not about the direction.

Where the canadian access and provincial variation discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.

0 likes 18mo
MI
m.ilungaTL27 Feb 2025#65

Appeals succeed more often than people expect when they answer the stated criterion point by point and include nothing else.

7 likes 18mo
CB
careful_beginnerTL1Member7 Feb 2025#66

I read the earlier replies on canadian access and provincial variation twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said rather than what I expected.

17 likes 18mo
EM
e.mbekiTL28 Feb 2025#67
j.falk, post #29: Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier you are facing. I have separated what I observed from what I concluded, which does not always happen. Go to post

Sensible. I would want the same detail before I acted on it either.

0 likes in reply to #29 18mo
RH
revision_historyTL3Wiki editor8 Feb 2025#68

Worth separating two things that post #64 runs together.

A note on how canadian access and provincial variation gets discussed rather than on canadian access and provincial variation itself: the confident posts get the replies and the careful ones get ignored, and the careful ones have been right more often.

1 like 18mo
SD
s.dialloTL28 Feb 2025#69

The arithmetic in post #66 is right; the assumption feeding it is the part to check.

Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.

Caveat: everything above assumes the paperwork is what it says it is.

11 likes 18mo
PP
peak_purityTL3Analytical chemist8 Feb 2025#70

Answering the question post #68 raises rather than the one it answers.

On canadian access and provincial variation I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how threads get heated.

23 likes 18mo
IB
i.beaulieuTL29 Feb 2025#71

The most useful contribution is the current published criterion with a link and an access date, rather than an account of what happened to somebody.

0 likes 18mo
N
NLoughranTL3Regular9 Feb 2025#72

Bookmarking this. I will come back when I have something worth adding.

27 likes 18mo
BA
b.adeyemiTL29 Feb 2025#73
a.vermeulen, post #18: Canadian access and provincial variation is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring. Go to post

Post #71 put the caveat in the right place and I want to underline it.

The question underneath canadian access and provincial variation is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.

Write down what you would expect to see under each hypothesis before you collect anything. If they predict the same observation, collecting it will not help.

8 likes in reply to #18 18mo
I
IMainwaringTL3Regular9 Feb 2025#74
c.lundgren, post #2: I had written a reply contradicting the opening post and deleted it. Here is what survived. Two claims get bundled together under canadian access and provincial variation and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not. Almost every… Go to post

Building on post #71 rather than restating it.

Small correction to my own earlier position on canadian access and provincial variation. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore changes it entirely.

2 likes in reply to #2 18mo
NH
n.hartmannTL210 Feb 2025 · edited#75

Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria and the job is to make them checkable.

I have no interest in any supplier named above.

0 likes 18mo
ST
stopper_traceTL2Member10 Feb 2025#76

Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream healthcare.

20 likes 18mo
MA
m.amankwahTL210 Feb 2025#77
r.jhannsdttir, post #11: Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction. Go to post

The confident answers on canadian access and provincial variation and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.

5 likes in reply to #11 18mo
VS
vial_slopeTL3Regular10 Feb 2025#78

Taking post #75 at face value and following it one step further.

Adding the boring version of canadian access and provincial variation, because the interesting version keeps getting posted and the boring one is usually right.

Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.

0 likes 18mo
KB
k.batistaTL211 Feb 2025#79

Reading rather than contributing, but this is the most useful thread I have found on it.

28 likes 18mo
CR
crossover_reviewTL3Regular11 Feb 2025#80
VPoulsen, post #30: I read post #28 twice before replying, because I had assumed the opposite. I would be cautious about generalising from the canadian access and provincial variation example above. It is a good example. It is one example. Go to post

Picking up post #78: that is the part I would want checked first.

Both are useful and different. The account tells you what happens in practice; the criterion tells you what to write.

Happy to be the one who is wrong here if it settles the question.

14 likes in reply to #30 18mo
GT
g.tanakaTL3Regular11 Feb 2025#81

Speaking only to canadian access and provincial variation as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect.

1 like 18mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…
GPMYASKHFA+46 50 7.9k 5mo
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. Two things I would like separated before anyone answers on Coverage,…
SAEDERSGAK 4 62k 9mo
Follow-up: State-level differences that actually matter
State-level differences that actually matter — setting out what I have, and where I think it stops being reliable. A follow-up question about State-level differences that I did not know to ask the first time.…
YRNJMFRRO+90 96 4.1k 4mo
Coming back to: Telehealth prescribing models in the US
Posting this under the heading it deserves: Telehealth prescribing models in the US Everything below is what sits behind that. Telehealth prescribing models — I have the observation and I do not trust my…
LCNBHFTIEM+26 30 17k 17h
US compounding rules and how they changed
US compounding rules and how they changed — setting out what I have, and where I think it stops being reliable. Reporting a regional experience with the date and the jurisdiction attached, because an undated…
VNJVBCBSAE+62 68 1.4k 20mo

Related topics — sharing the tags compounding, telehealth, FDA

TopicParticipantsRepliesViewsActivity
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise — setting out what I have, and where I think it stops being reliable. Official shortage notices — I have the observation and I do not trust my interpretation…
DOFFAPRSRD+39 43 510 17mo
US compounding rules and how they changed
US compounding rules and how they changed — setting out what I have, and where I think it stops being reliable. Reporting a regional experience with the date and the jurisdiction attached, because an undated…
VNJVBCBSAE+62 68 1.4k 20mo
[2026 update] Travelling with an injectable: documentation and practicalities
Travelling with an injectable: documentation and practicalities Writing it up because I had to work it out twice and would rather nobody else did. Dated regional question, February 2026, because everything in…
VSDAWIBB+107 111 12k 1d
Prescription portability between countries
Prescription portability between countries — setting out what I have, and where I think it stops being reliable. Asking about prescription portability between countries directly, because I have read four…
SGTLDCIAL+104 114 6.1k 3h
State-level differences that actually matter
On the subject in the title: State-level differences that actually matter Working notes rather than a conclusion. The question about state-level differences that I actually want answered is the second one…
TPJVSRGVGE+6 10 56k 10mo